What is the recommended evaluation and management for an adult female with Ehlers‑Danlos syndrome?

Evaluation and Management of Adult Female with Ehlers-Danlos Syndrome

Adult females with suspected or confirmed EDS require genetic testing to exclude alternative diagnoses (critical in 26.4% of cases), followed by subtype-specific management focusing on cardiovascular surveillance, gastrointestinal symptoms with autonomic dysfunction, and physical therapy as the cornerstone of treatment 1, 2.

Initial Diagnostic Approach

Confirm Diagnosis and Exclude Alternatives

• Genetic testing is mandatory even when clinical criteria appear met, as 26.4% of patients meeting 2017 hEDS criteria actually have alternative diagnoses requiring different management 1
• For hypermobile EDS (hEDS) - the most common subtype (80-90% of EDS cases) - diagnosis requires three criteria: generalized joint hypermobility (Beighton score >5), musculoskeletal/systemic manifestations of connective tissue disorder, and exclusion of other conditions 2, 1
• Genetic testing identifies the specific EDS subtype in 13 of 14 recognized types, with only hEDS lacking a known molecular cause 3

Subtype Matters for Management

The distinction between vascular EDS (vEDS) and other subtypes is life-critical. vEDS requires COL3A1 variant identification and carries risk of arterial rupture, bowel perforation, and uterine rupture during pregnancy 4. This fundamentally changes surveillance and pregnancy counseling.

Mandatory Baseline Evaluations

Cardiovascular Assessment

• Echocardiography is essential - 43% of EDS patients show aortic root dilatation or valve prolapse 5
• For vEDS specifically: annual vascular surveillance with Doppler ultrasound, CTA (low radiation), or MRA 4
• Blood pressure control is critical; treat hypertension aggressively 4

Bone Health

• Bone mineral density testing is required - all patients in one study demonstrated osteoporosis 5
• This is particularly relevant for adult females given baseline osteoporosis risk

Gastrointestinal Evaluation

Given that 98% of hEDS/HSD patients meet criteria for disorders of gut-brain interaction 2:

• Screen for chronic upper GI symptoms, particularly with comorbid POTS
• Consider gastric emptying studies and accommodation testing after excluding structural disease 2
• Assess for mast cell activation syndrome (MCAS) symptoms: reactions to foods, temperature changes, mechanical stimuli, emotional stress 2

Management Framework

Physical Therapy - Primary Intervention

Physical therapy is the central treatment modality for hEDS/HSD, though evidence quality remains limited 6. Focus on:

• Joint stabilization exercises
• Proprioceptive training
• Activity modification to minimize injury risk 4

Gastrointestinal Management

A hierarchical approach 2:

1. Treat the most prominent GI symptoms based on function test results

2. Address POTS if present:

   • First-line: increase fluid and salt intake, exercise training, compression garments
   • Second-line: pharmacological volume expansion, heart rate control, vasoconstriction with cardiology/neurology consultation 2

3. Manage MCAS when suspected:

   • Histamine receptor antagonists and/or mast cell stabilizers
   • Trigger avoidance: specific foods, alcohol, strong smells, temperature changes, friction, emotional distress, certain medications (opioids, NSAIDs, iodinated contrast) 2

4. Dietary interventions with nutritional counseling:

   • Gastroparesis diet (small particle diet)
   • Elimination diets: low fermentable carbohydrates, gluten-free, dairy-free, low-histamine
   • Critical caveat: Must have nutritional guidance to avoid restrictive eating pitfalls 2

Pregnancy Considerations for Women

This is particularly relevant for adult females 7:

• Preconception counseling is mandatory - especially critical for vEDS due to uterine rupture risk 5, 4
• Multidisciplinary team required: maternal-fetal medicine, genetics, cardiology, anesthesiology
• Address tissue fragility, joint hypermobility, pain management
• Screen and manage dysautonomia and mast cell diseases during pregnancy 7
• Increased risk of: premature rupture of membranes (19%), prematurity (19%), complications from tissue fragility 5

Lifestyle Modifications

• Modulate lifestyle to minimize injury risk - avoid contact sports, heavy lifting 4
• Maintain blood pressure in normal range 4
• Create individualized emergency care plan ("vascular EDS passport" for vEDS) 4

Common Pitfalls to Avoid

1. Assuming clinical diagnosis is sufficient - genetic testing changes management in over 1 in 4 cases 1
2. Missing cardiovascular complications - systematic echocardiographic surveillance prevents catastrophic outcomes 5
3. Overlooking POTS and MCAS - these comorbidities are extremely common and treatable 2
4. Restrictive diets without supervision - can lead to malnutrition 2
5. Dismissing patient symptoms - the diagnostic journey averages 10-12 years, and patients often educate their providers 8

Surveillance Strategy

• Annual cardiovascular imaging (especially vEDS) 4
• Periodic bone density assessment 5
• Ongoing GI symptom monitoring with function testing as needed 2
• Centralize care at centers of excellence when feasible 4

The 2017 diagnostic criteria for hEDS have been criticized as overly stringent, potentially missing patients who would benefit from proper diagnosis and management 9. When clinical suspicion is high but criteria aren't fully met, consider HSD diagnosis and apply similar management principles, while maintaining surveillance for evolving features.